Testosterone Therapy

FDA Warns of Potential for Testosterone Abuse

fda warning on testosterone abuseAs we’ve seen with the opioid epidemic sweeping across the country, the more available a prescription drug becomes, the greater the potential seems to become for that prescription drug to be abused. As drug companies flood American cities and towns with more painkillers than they could possibly take under normally-prescribed conditions, the number of overdoses and deaths has skyrocketed.

Sadly, that same kind of dependency and abuse is now starting to show itself ...

continue reading...

Life Time Fitness Sued By In-House Testosterone Clinic Partner

life time fitness sued by low t centerRegardless of the controversies surrounding testosterone therapy and the associated lawsuits, many people assume that there is still, at least, an actual medical condition which warrants some kind of medical treatment with testosterone. A new suit filed against Life Time Fitness, however, may call cause some to rethink that assumption.

In 2014, Life Time Fitness chose a company called Low T Center as its partner to offer testosterone ...

continue reading...

Federal Testosterone Therapy Lawsuits Top 3,000

3000 cases in testosterone therapy lawsuitsAccording to recent data from the U.S. Judicial Panel on Multidistrict Litigation, the number of testosterone therapy lawsuits pending in federal court has climbed to 3,238. The Illinois multidistrict litigation, established in June 2014, initially included just eight testosterone lawsuits.

Popular Low-T drugs like AndroGel, Axiron, and Testim are approved by the U.S. Food and Drug Administration (FDA) for use in men whose testosterone is low due to a medical ...

continue reading...

Judge Refuses to Drop AndroGel Co-Manufacturer from Testosterone MDL

judge refuses to drop androgen manufacturer from testosterone therapy lawsuitJudge Matthew Kennelly of the U.S. District Court for the District of Northern Illinois has denied Belgian company Besins Healthcare’s motion to dismiss itself from a multidistrict testosterone litigation, the Cook County Record reports. Along with AbbVie, Besins is responsible for the manufacture of AndroGel, one of the leading brands of testosterone therapy that have been targeted in a massive multi-state litigation.

Testosterone replacement therapy is ...

continue reading...

Endocrinology Groups Echo FDA Call for More Research on Testosterone Therapy Risks

endocrinologist group calls for testosterone therapy researchThe American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE) recently issued a joint position statement on the cardiovascular risks of testosterone therapy. In the statement, the two endocrinology groups questioned the FDA’s recommended method for determining whether a patient requires testosterone therapy and call for more research on the health risks posed by Low-T products.

The FDA has indicated that testosterone therapy is approved ...

continue reading...

AbbVie Unhappy with Testosterone MDL Bellwether Trial Selection

abbvie not happy with bellwether trail selectionAbbVie, maker of the popular testosterone therapy product AndroGel, has expressed dissatisfaction with the federal court’s bellwether trial selection process, Forbes reports. The U.S. District Court for the Northern District of Illinois has chosen AbbVie to defend in the first MDL testosterone lawsuit to go to trial. AbbVie, a defendant in the fast-growing Illinois testosterone therapy MDL, has been instructed to select 32 potential cases to be prepared for bellwether ...

continue reading...
Page 2 of 8 12345...»